Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 7.00M | $ 0.00 | $ 6.80M | $ 11.10M | $ 7.20M |
Total Assets | $ 2.73B | $ 2.76B | $ 2.56B | $ 2.56B | $ 2.54B |
Total Debt | $ 679.40M | $ 589.70M | $ ― | $ 533.20M | $ ― |
Net Debt | $ 672.40M | $ 589.70M | $ ― | $ 522.10M | $ ― |
Total Liabilities | $ 720.10M | $ 644.90M | $ 542.80M | $ 588.30M | $ 511.30M |
Stockholders Equity | $ 2.01B | $ 2.11B | $ 2.02B | $ 1.97B | $ 2.03B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |